← Evidence map

ArticleCell death discovery2021

MDM2 inhibitor APG-115 exerts potent antitumor activity and synergizes with standard-of-care agents in preclinical acute myeloid leukemia models.

Douglas D Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

36 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33941774